Cadrenal Therapeutics Price Chart
Cadrenal Therapeutics Volume Chart
Cadrenal Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.03(+0.57%)
| Open | $5.25 |
|---|---|
| Close | $5.28 |
| Low | $5.25 |
| Low Change | 0.00 (0.00%) |
| High | $5.28 |
| High Change | +0.03 (+0.57%) |
| Range | $0.03 |
| Volume | 315 |
| Dollar Volume | $1.66K |
Regular Trading Hours Yesterday
-0.15(-2.76%)
| Open | $5.43 |
|---|---|
| Close | $5.28 |
| Low | $5.02 |
| Low Change | -0.41 (-7.55%) |
| High | $5.57 |
| High Change | +0.14 (+2.58%) |
| Range | $0.55 |
| Volume | 45.537K |
| Dollar Volume | $240.44K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $5.71 |
|---|---|
| Close | $5.71 |
| Low | $5.71 |
| Low Change | 0.00 (0.00%) |
| High | $5.71 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 123 |
| Dollar Volume | $702.69 |
Cadrenal Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.51 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.91 |
| 20 Day Moving Average (SMA20) | $5.73 |
| 50 Day Moving Average (SMA50) | $5.88 |
| 100 Day Moving Average (SMA100) | $6.52 |
| 200 Day Moving Average (SMA200) | $9.32 |
Cadrenal Therapeutics Statistics
| Average Volume (30 Days) | 58.27K |
|---|---|
| P/E Ratio (Current) | -1.23 |
| EPS (Current) | -$4.30 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$12.61M |
| Cash Ratio | 2.52 |
| Current Ratio | 2.72 |
| Quick Ratio | 2.72 |
| Debt to Equity | 0.00 |
| Enterprise Value | $12.34M |
| EV to EBITDA | -0.92 |
| EV to Sales | — |
| Price to Book | 5.97 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -3.06% |
| Return on Equity | -4.83% |
Cadrenal Therapeutics Stock Splits
There has been 1 stock split for Cadrenal Therapeutics (CVKD). The reverse stock split occured on August 20, 2024 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Aug 20, 2024 | Reverse | 15:1 |
Cadrenal Therapeutics Dividends
There have been no dividends for Cadrenal Therapeutics (CVKD).